Shareholders accuse Seattle health startup of 'misleading investors' after IPO
SEATTLE — Some investors in a Seattle-based drug company claim leaders misled investors ahead of its initial public offering, and are pursuing a class-action lawsuit against the fledgling company.
Source: columbian.com